CN Patent

CN1289500C — 氮杂双环化合物,它们的制备方法以及它们作为药物的应用,特别地作为抗菌剂的应用

Assigned to Pfizer Ireland Pharmaceuticals · Expires 2006-12-13 · 19y expired

What this patent protects

本发明涉及新的通式(I)杂环化合物，它们与酸或碱的盐。本发明还涉及这些化合物的制备方法，以及它们作为药物的应用，特别地作为抗菌剂的应用。

USPTO Abstract

本发明涉及新的通式(I)杂环化合物，它们与酸或碱的盐。本发明还涉及这些化合物的制备方法，以及它们作为药物的应用，特别地作为抗菌剂的应用。

Drugs covered by this patent

Patent Metadata

Patent number: CN1289500C
Jurisdiction: CN
Classification: —
Expires: 2006-12-13
Drug substance claim: No
Drug product claim: No
Assignee: Pfizer Ireland Pharmaceuticals
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.